Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 5Stomach Neoplasms 4Neuroblastoma 4Fallopian Tube Neoplasms 4Urinary Bladder Neoplasms 3Ovarian Neoplasms 3Medulloblastoma 3Ganglioneuroblastoma 3Gallbladder Neoplasms 3Cholangiocarcinoma 3Brain Neoplasms 3Urethral Neoplasms 2Ureteral Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Hepatocellular 2Brenner Tumor 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Triple Negative Breast Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Solid Neoplasms 1Sarcoma 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1

Interventions

Fluorouracil 2Capecitabine 2tremelimumab 1trametinib 1temoporfin 1durvalumab 1dehydroftorafur 1Sorafenib 1Self Expandable Metallic Stents 1Radiosurgery 1Platinum 1Oxaliplatin 1N-Ac-CHAVC-NH2 1Leucovorin 1Hydroxychloroquine 1Gemcitabine 1Erlotinib Hydrochloride 1Cisplatin 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Klatskin Tumor × Platinum × Clear all
NCT01825603 2023-12-28

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

University of Nebraska

Phase 1 Completed
17 enrolled
Gastrointestinal

Gallbladder Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡